+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895118
The ambulatory cardiac monitoring devices market was valued USD 6.4 billion in 2023, driven by differences in healthcare infrastructure, patient awareness, and economic factors across the globe. The market size is anticipated to grow at a CAGR of 10% during the forecast period of 2024-2032 to achieve a value of USD 15 billion by 2032.

Ambulatory Cardiac Monitoring Devices: Introduction

Ambulatory cardiac monitoring devices are medical devices designed to monitor and record a patient's heart activity over an extended period, typically outside of a hospital or clinical setting. These devices are used to diagnose and track various cardiac conditions, such as arrhythmias, palpitations, and other irregularities in heart rhythm. Unlike traditional in-hospital monitoring, ambulatory cardiac monitoring allows patients to continue their daily activities while their heart's electrical activity is continuously recorded and analyzed. These devices have become integral tools in cardiology, enabling accurate diagnosis, informed treatment decisions, and improved management of cardiac conditions. As technology advances, ambulatory cardiac monitoring devices continue to evolve, offering enhanced features for data analysis, patient comfort, and seamless integration with healthcare systems.

Key Trends in the Ambulatory Cardiac Monitoring Devices Market

  • Technological Advancements: The ambulatory cardiac monitoring devices market was witnessing continuous technological advancements, leading to the development of smaller, more comfortable, and user-friendly devices. These advancements included improved ECG sensors, wireless connectivity, longer battery life, and enhanced data analysis capabilities.
  • Remote Monitoring and Telehealth Integration: The integration of ambulatory cardiac monitoring devices with telehealth platforms and remote monitoring systems was becoming more prevalent. This trend was driven by the need for continuous patient monitoring, especially during the COVID-19 pandemic, when remote healthcare services gained prominence.
  • Wearable Devices: Wearable ambulatory cardiac monitoring devices, such as patch monitors and smartwatches with ECG capabilities, were gaining popularity. These devices offered convenience, comfort, and real-time data transmission, allowing patients and healthcare professionals to monitor heart activity more effectively.
  • Data Analytics and Artificial Intelligence: Data generated by ambulatory cardiac monitoring devices were increasingly being analyzed using advanced data analytics and artificial intelligence (AI) algorithms. These technologies helped identify patterns, anomalies, and trends in cardiac data, aiding in more accurate diagnosis and personalized treatment planning.

Ambulatory Cardiac Monitoring Devices Market Segmentations

The market can be categorised into type, end user, and region.

Market Breakup by Type

ECG Devices

  • Resting ECG Devices
  • Stress ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Care Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Ambulatory Cardiac Monitoring Devices Market Overview

The ambulatory cardiac monitoring devices market was experiencing significant growth and transformation due to the increasing prevalence of cardiac conditions, technological advancements, and the growing adoption of remote monitoring solutions. The ambulatory cardiac monitoring devices market was witnessing steady growth, driven by the rising incidence of cardiac arrhythmias, heart diseases, and related conditions. The global market was projected to expand due to the increasing awareness of cardiovascular health, especially among aging populations. The market's reach was global, with demand and adoption varying across regions due to differences in healthcare infrastructure, patient awareness, and economic factors.

In North America, a mature healthcare system and prevalent cardiac conditions led to a substantial market share for ambulatory cardiac monitoring devices. Advancements in technology, favourable reimbursement, and heightened heart health awareness drove growth. Europe, including the UK, Germany, and France, saw a significant presence due to well-established healthcare and digital health integration. The Asia Pacific region's adoption rose with cardiovascular disease burden and heart health awareness, especially in China, Japan, India, and Australia, benefiting from improved healthcare and technology. Latin America's demand grew, driven by expanding access and cardiac awareness in countries like Brazil, Mexico, and Argentina, aided by economic factors and medical tech progress. The Middle East and parts of Africa gradually expanded due to improved healthcare, awareness campaigns, and economic development fostering ambulatory cardiac monitoring device adoption.

Key Players in the Ambulatory Cardiac Monitoring Devices Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in ambulatory cardiac monitoring devices market are as follows:

  • Abbott
  • Boston Scientific Corporation
  • GE Healthcare
  • Cardinal Health
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • Asahi Kasei Corporation
  • BIOTRONIK SE & Co KG
  • BPL Medical Technologies
  • iRhythm Technologies, Inc.
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ambulatory Cardiac Monitoring Devices Market Overview
3.1 Global Ambulatory Cardiac Monitoring Devices Market Historical Value (2017-2023)
3.2 Global Ambulatory Cardiac Monitoring Devices Market Forecast Value (2024-2032)
4 Global Ambulatory Cardiac Monitoring Devices Market Landscape
4.1 Global Ambulatory Cardiac Monitoring Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ambulatory Cardiac Monitoring Devices Product Landscape
4.2.1 Analysis by Type
5 Global Ambulatory Cardiac Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ambulatory Cardiac Monitoring Devices Market Segmentation
6.1 Global Ambulatory Cardiac Monitoring Devices Market by Type
6.1.1 Market Overview
6.1.2 ECG Devices
6.1.2.1 Resting ECG Devices
6.1.2.2 Stress ECG Devices
6.1.3 Holter Monitors
6.1.4 Event Monitors
6.1.5 Implantable Loop Recorders
6.1.6 Mobile Cardiac Telemetry
6.2 Global Ambulatory Cardiac Monitoring Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Clinics
6.2.3 Ambulatory Care Centers
6.2.4 Others
6.3 Global Ambulatory Cardiac Monitoring Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Ambulatory Cardiac Monitoring Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ambulatory Cardiac Monitoring Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ambulatory Cardiac Monitoring Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ambulatory Cardiac Monitoring Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ambulatory Cardiac Monitoring Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GE Healthcare
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hill-Rom Holdings
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Koninklijke Philips N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medtronic
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nihon Kohden Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Asahi Kasei Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BIOTRONIK SE & Co KG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 BPL Medical Technologies
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iRhythm Technologies, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Ambulatory Cardiac Monitoring Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Abbott
  • Boston Scientific Corporation
  • GE Healthcare
  • Cardinal Health
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • Asahi Kasei Corporation
  • BIOTRONIK SE & Co KG
  • BPL Medical Technologies
  • iRhythm Technologies Inc.

Methodology

Loading
LOADING...